Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial.
- 2024-06-15
- RCT · n = 150
- Trials 25(1)
- Thomas Radtke
- Lisa Künzi
- Julia Kopp
- Manuela Rasi
- Julia Braun
- Kyra D Zens
- Babette Winter
- Alexia Anagnostopoulos
- Milo A Puhan
- Jan S Fehr
- PubMed: 38879571
- DOI: 10.1186/s13063-024-08187-6
- High evidence
- Large Human Trial
- Clinical
Secondary endpoints include ... blood biomarkers for ... inflammation
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 200 mg daily